Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole trough concentration and CYP2C19 polymorphism in Chinese adults with invasive pulmonary aspergillosis
ChiCTR-ONC-14004339Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in Acute Invasive Aspergillosis, sponsored by Qilu Hospital of Shandong University. Primary endpoints: CYP2C19 genotyping, Voriconazole trough concentration and 5 more. Started Jun 2014; status: completed.
02
Drugs
voriconazole
03
Conditions
Acute Invasive Aspergillosis
Beyond the preview
Go deeper on ChiCTR-ONC-14004339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-14004339.